Converging Pharmacological and Genetic Evidence Indicates a Role for Steroid Sulfatase in Attention

Biological Psychiatry

Volumn 66, Issue 4, 2009, Pages 360-367

  Davies, William ^a   Humby, Trevor ^a   Kong, Wendy ^b   Otter, Tamara ^a   Burgoyne, Paul S ^c   Wilkinson, Lawrence S ^a  

^a Unit of Psychology   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

5 choice serial reaction time task; Accuracy; attention deficit hyperactivity disorder; dehydroepiandrosterone sulfate; Turner syndrome; X chromosome

Indexed keywords

ENZYME INHIBITOR; PRASTERONE SULFATE; STEROID SULFATASE INHIBITOR; STERYL SULFATASE; UNCLASSIFIED DRUG;

ACCURACY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; ENZYME INHIBITION; LATENT PERIOD; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPONSE TIME; TASK PERFORMANCE; X CHROMOSOME LINKAGE;

ANIMALS; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHOICE BEHAVIOR; COUMARINS; DEHYDROEPIANDROSTERONE SULFATE; MALE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MOTOR ACTIVITY; REACTION TIME; STERYL-SULFATASE; SULFONAMIDES;

EID: 67651154172     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2009.01.001     Document Type: Article

References (61)

1. Thapar A., O'Donovan M., and Owen M.J. The genetics of attention deficit hyperactivity disorder. Hum Mol Genet 14 Spec No. 2 (2005) R275-R282
2. Banerjee T.D., Middleton F., and Faraone S.V. Environmental risk factors for attention-deficit hyperactivity disorder. Acta Paediatr 96 (2007) 1269-1274
3. Wallis D., Russell H.F., and Muenke M. Genetics of attention deficit/hyperactivity disorder. J Pediatr Psychol 33 (2008) 1085-1099
4. Holden C. Sex and the suffering brain. Science 308 (2005) 1574
5. Bauermeister J.J., Shrout P.E., Chavez L., Rubio-Stipec M., Ramirez R., Padilla L., et al. ADHD and gender: Are risks and sequela of ADHD the same for boys and girls?. J Child Psychol Psychiatry 48 (2007) 831-839
6. Rasmussen K., and Levander S. Untreated ADHD in adults: Are there sex differences in symptoms, comorbidity, and impairment?. J Atten Disord 12 (2009) 353-360
7. Rucklidge J.J. Gender differences in ADHD: Implications for psychosocial treatments. Expert Rev Neurother 8 (2008) 643-655
8. Ross J.L., Stefanatos G.A., Kushner H., Zinn A., Bondy C., and Roeltgen D. Persistent cognitive deficits in adult women with Turner syndrome. Neurology 58 (2002) 218-225
9. Rovet J., and Ireland L. Behavioral phenotype in children with Turner syndrome. J Pediatr Psychol 19 (1994) 779-790
10. Temple C.M., Carney R.A., and Mullarkey S. Frontal lobe function and executive skills in children with Turner's syndrome. Dev Neuropsychol 12 (1996) 343-363
11. Russell H.F., Wallis D., Mazzocco M.M., Moshang T., Zackai E., Zinn A.R., et al. Increased prevalence of ADHD in Turner syndrome with no evidence of imprinting effects. J Pediatr Psychol 31 (2006) 945-955
12. Davies W., Humby T., Isles A.R., Burgoyne P.S., and Wilkinson L.S. X-monosomy effects on visuospatial attention in mice: A candidate gene and implications for Turner syndrome and attention deficit hyperactivity disorder. Biol Psychiatry 61 (2007) 1351-1360
13. Carrel L., and Willard H.F. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434 (2005) 400-404
14. Reed M.J., Purohit A., Woo L.W., Newman S.P., and Potter B.V. Steroid sulfatase: Molecular biology, regulation, and inhibition. Endocr Rev 26 (2005) 171-202
15. Wolf O.T., and Kirschbaum C. Actions of dehydroepiandrosterone and its sulfate in the central nervous system: Effects on cognition and emotion in animals and humans. Brain Res Brain Res Rev 30 (1999) 264-288
16. Compagnone N.A., Salido E., Shapiro L.J., and Mellon S.H. Expression of steroid sulfatase during embryogenesis. Endocrinology 138 (1997) 4768-4773
17. Mortaud S., Donsez-Darcel E., Roubertoux P.L., and Degrelle H. Murine steroid sulfatase gene expression in the brain during postnatal development and adulthood. Neurosci Lett 215 (1996) 145-148
18. Steckelbroeck S., Nassen A., Ugele B., Ludwig M., Watzka M., Reissinger A., et al. Steroid sulfatase (STS) expression in the human temporal lobe: Enzyme activity, mRNA expression and immunohistochemistry study. J Neurochem 89 (2004) 403-417
19. Purohit A., Fusi L., Brosens J., Woo L.W., Potter B.V., and Reed M.J. Inhibition of steroid sulphatase activity in endometriotic implants by 667 COUMATE: A potential new therapy. Hum Reprod 23 (2008) 290-297
20. Purohit A., Woo L.W., Chander S.K., Newman S.P., Ireson C., Ho Y., et al. Steroid sulphatase inhibitors for breast cancer therapy. J Steroid Biochem Mol Biol 86 (2003) 423-432
21. Nicolas L.B., Pinoteau W., Papot S., Routier S., Guillaumet G., and Mortaud S. Aggressive behavior induced by the steroid sulfatase inhibitor COUMATE and by DHEAS in CBA/H mice. Brain Res 922 (2001) 216-222
22. Doherty M.J., Glass I.A., Bennett C.L., Cotter P.D., Watson N.F., Mitchell A.L., et al. An Xp; Yq translocation causing a novel contiguous gene syndrome in brothers with generalized epilepsy, ichthyosis, and attention deficits. Epilepsia 44 (2003) 1529-1535
23. Kent L., Emerton J., Bhadravathi V., Weisblatt E., Pasco G., Willatt L.R., et al. X linked ichthyosis (steroid sulphatase deficiency) is associated with increased risk of attention deficit hyperactivity disorder, autism and social communication deficits. J Med Genet (2008) [published online ahead of print April 15].
24. Lonardo F., Parenti G., Luquetti D.V., Annunziata I., Della Monica M., Perone L., et al. Contiguous gene syndrome due to an interstitial deletion in Xp22.3 in a boy with ichthyosis, chondrodysplasia punctata, mental retardation and ADHD. Eur J Med Genet 50 (2007) 301-308
25. Tobias E.S., Bryce G., Farmer G., Barton J., Colgan J., Morrison N., et al. Absence of learning difficulties in a hyperactive boy with a terminal Xp deletion encompassing the MRX49 locus. J Med Genet 38 (2001) 466-470
26. Goodman D.W. The consequences of attention-deficit/hyperactivity disorder in adults. J Psychiatr Pract 13 (2007) 318-327
27. Odorisio T., Rodriguez T.A., Evans E.P., Clarke A.R., and Burgoyne P.S. The meiotic checkpoint monitoring synapsis eliminates spermatocytes via p53-independent apoptosis. Nat Genet 18 (1998) 257-261
28. Burgoyne P.S., Mahadevaiah S.K., Perry J., Palmer S.J., and Ashworth A. The Y* rearrangement in mice: New insights into a perplexing PAR. Cytogenet Cell Genet 80 (1998) 37-40
29. Humby T., Laird F.M., Davies W., and Wilkinson L.S. Visuospatial attentional functioning in mice: Interactions between cholinergic manipulations and genotype. Eur J Neurosci 11 (1999) 2813-2823
30. Robbins T.W. The 5-choice serial reaction time task: Behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl) 163 (2002) 362-380
31. Noda Y., Kamei H., Kamei Y., Nagai T., Nishida M., and Nabeshima T. Neurosteroids ameliorate conditioned fear stress: An association with sigma receptors. Neuropsychopharmacology 23 (2000) 276-284
32. Chudasama Y., Passetti F., Rhodes S.E., Lopian D., Desai A., and Robbins T.W. Dissociable aspects of performance on the 5-choice serial reaction time task following lesions of the dorsal anterior cingulate, infralimbic and orbitofrontal cortex in the rat: Differential effects on selectivity, impulsivity and compulsivity. Behav Brain Res 146 (2003) 105-119
33. Nicolas L.B., and Fry J.P. The steroid sulfatase inhibitor COUMATE attenuates rather than enhances access of dehydroepiandrosterone sulfate to the brain in the mouse. Brain Res 1174 (2007) 92-96
34. Ritsner M.S., Gibel A., Ratner Y., Tsinovoy G., and Strous R.D. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: A randomized, double-blind, placebo-controlled, crossover trial. J Clin Psychopharmacol 26 (2006) 495-499
35. Maayan R., Yoran-Hegesh R., Strous R., Nechmad A., Averbuch E., Weizman A., and Spivak B. Three-month treatment course of methylphenidate increases plasma levels of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone-sulfate (DHEA-S) in attention deficit hyperactivity disorder. Neuropsychobiology 48 (2003) 111-115
36. Young J.W., Finlayson K., Spratt C., Marston H.M., Crawford N., Kelly J.S., and Sharkey J. Nicotine improves sustained attention in mice: Evidence for involvement of the alpha7 nicotinic acetylcholine receptor. Neuropsychopharmacology 29 (2004) 891-900
37. Karishma K.K., and Herbert J. Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression. Eur J Neurosci 16 (2002) 445-453
38. Eagle D.M., Bari A., and Robbins T.W. The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks. Psychopharmacology (Berl) 199 (2008) 439-456
39. Isles A.R., Humby T., and Wilkinson L.S. Measuring impulsivity in mice using a novel operant delayed reinforcement task: Effects of behavioural manipulations and d-amphetamine. Psychopharmacology (Berl) 170 (2003) 376-382
40. Dhir A., and Kulkarni S. Involvement of sigma (sigma1) receptors in modulating the anti-depressant effect of neurosteroids (dehydroepiandrosterone or pregnenolone) in mouse tail-suspension test. J Psychopharmacol 22 (2008) 691-696
41. Connor D.F., and Doerfler L.A. ADHD with comorbid oppositional defiant disorder or conduct disorder: Discrete or nondistinct disruptive behavior disorders?. J Atten Disord 12 (2007) 126-134
42. Risbrough V., Bontempi B., and Menzaghi F. Selective immunolesioning of the basal forebrain cholinergic neurons in rats: Effect on attention using the 5-choice serial reaction time task. Psychopharmacology (Berl) 164 (2002) 71-81
43. Inglis W.L., Olmstead M.C., and Robbins T.W. Selective deficits in attentional performance on the 5-choice serial reaction time task following pedunculopontine tegmental nucleus lesions. Behav Brain Res 123 (2001) 117-131
44. McKinney M., and Jacksonville M.C. Brain cholinergic vulnerability: Relevance to behavior and disease. Biochem Pharmacol 70 (2005) 1115-1124
45. Rhodes M.E., Li P.K., Burke A.M., and Johnson D.A. Enhanced plasma DHEAS, brain acetylcholine and memory mediated by steroid sulfatase inhibition. Brain Res 773 (1997) 28-32
46. Rhodes M.E., Li P.K., Flood J.F., and Johnson D.A. Enhancement of hippocampal acetylcholine release by the neurosteroid dehydroepiandrosterone sulfate: An in vivo microdialysis study. Brain Res 733 (1996) 284-286
47. Arias H.R., Bhumireddy P., and Bouzat C. Molecular mechanisms and binding site locations for noncompetitive antagonists of nicotinic acetylcholine receptors. Int J Biochem Cell Biol 38 (2006) 1254-1276
48. George O., Vallee M., Le Moal M., and Mayo W. Neurosteroids and cholinergic systems: Implications for sleep and cognitive processes and potential role of age-related changes. Psychopharmacology (Berl) 186 (2006) 402-413
49. Potter A.S., Newhouse P.A., and Bucci D.J. Central nicotinic cholinergic systems: a role in the cognitive dysfunction in attention-deficit/hyperactivity disorder?. Behav Brain Res 175 (2006) 201-211
50. Rowe D.L., and Hermens D.F. Attention-deficit/hyperactivity disorder: Neurophysiology, information processing, arousal and drug development. Expert Rev Neurother 6 (2006) 1721-1734
51. Park-Chung M., Malayev A., Purdy R.H., Gibbs T.T., and Farb D.H. Sulfated and unsulfated steroids modulate gamma-aminobutyric acidA receptor function through distinct sites. Brain Res 830 (1999) 72-87
52. Isles A.R., Davies W., Burrmann D., Burgoyne P.S., and Wilkinson L.S. Effects on fear reactivity in XO mice are due to haploinsufficiency of a non-PAR X gene: Implications for emotional function in Turner's syndrome. Hum Mol Genet 13 (2004) 1849-1855
53. Baunez C., and Robbins T.W. Effects of transient inactivation of the subthalamic nucleus by local muscimol and APV infusions on performance on the five-choice serial reaction time task in rats. Psychopharmacology (Berl) 141 (1999) 57-65
54. Mohler H. Molecular regulation of cognitive functions and developmental plasticity: Impact of GABAA receptors. J Neurochem 102 (2007) 1-12
55. Lena C., and Changeux J.P. Role of Ca2+ ions in nicotinic facilitation of GABA release in mouse thalamus. J Neurosci 17 (1997) 576-585
56. Bellgrove M.A., and Mattingley J.B. Molecular genetics of attention. Ann N Y Acad Sci 1129 (2008) 200-212
57. Lee J., Laurin N., Crosbie J., Ickowicz A., Pathare T., Malone M., et al. Association study of the nicotinic acetylcholine receptor alpha4 subunit gene, CHRNA4, in attention-deficit hyperactivity disorder. Genes Brain Behav 7 (2008) 53-60
58. Todd R.D., Lobos E.A., Sun L.W., and Neuman R.J. Mutational analysis of the nicotinic acetylcholine receptor alpha 4 subunit gene in attention deficit/hyperactivity disorder: Evidence for association of an intronic polymorphism with attention problems. Mol Psychiatry 8 (2003) 103-108
59. Kawai H., Zago W., and Berg D.K. Nicotinic alpha 7 receptor clusters on hippocampal GABAergic neurons: Regulation by synaptic activity and neurotrophins. J Neurosci 22 (2002) 7903-7912
60. Hoyle E., Genn R.F., Fernandes C., and Stolerman I.P. Impaired performance of alpha7 nicotinic receptor knockout mice in the five-choice serial reaction time task. Psychopharmacology (Berl) 189 (2006) 211-223
61. Brookes K.J., Hawi Z., Kirley A., Barry E., Gill M., and Kent L. Association of the steroid sulfatase (STS) gene with attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 147 (2008) 1531-1535